Why Ainos, Inc.’s (AIMD) Stock Is Up 6.74%
As of Wednesday, July 02, Ainos, Inc.’s AIMD share price has surged by 6.74%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Stock Evaluator: Ainos, Inc. (AIMD)
Ainos, Inc. AIMD
$1.48
-0.12
-7.50%
September 8, 2026 4:00:00 PM
EST
Volume: 40,739
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Information Technology | Technology Hardware, Storage & Peripherals |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women’s health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.
Commentary & Analysis
Is Ainos Inc (AIMD) Stock a Good Investment?
Learn more about Ainos Inc's (AIMD) stock grades for Value, Momentum and Growth and determine whether this Biotechnology & Medical Research stock meets your investment needs.Jack Gilleland
Financial Summary
| Share Statistics | AIMD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $11.8 | $1,813.0 | 7% |
|
| Shares Out (Mil) | 7.4 | 33.3 | 17% |
|
| Institutional Ownership | 6.8% | 72.5% | 5% |
|
| Float (Mil) | 2.4 | 141.6 | 6% |
|
| Beta | 2.48 | 1.22 | 96% |
|
| Avg Daily Volume (000s) | 24 | 379 | 22% |
|
| Price Change (52-week) |
(55.9%) | 74.6% | 13% |
|
| Growth | AIMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 0.4% | na |
|
| Net Income (5yr) | (58.1%) | 1.2% | 5% |
|
| EPS (5yr) | 23.7% | 13.6% | 74 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 25.6% | (7.3%) | 83% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | AIMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $2,655 | na |
|
| Net Income (TTM) (Mil) | ($15) | $5 | 26% |
|
| EPS (TTM) | ($2.494) | $0.100 | 13% |
|
| Operating Cash Flow (TTM) (Mil) | ($5) | $78 | 25% |
|
| Net Cash Flow (TTM) (Mil) | $0 | $8 | 43% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $129 | 0% |
|
| Enterprise Value (Q1) (Mil) | $23 | $2,354 | 12% |
|
| Valuation | AIMD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.64 | 2.69 | 70% |
|
| P/E | na | 26.2 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.8 | na |
|
| Ratios | AIMD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 78.7% | 35.1% | 88% |
|
| Net Margin | na | 2.0% | na |
|
| ROA | (66.5%) | 1.2% | 9% |
|
| ROE | (196.3%) | 5.3% | 4% |
|
| Liabilities to Assets | 83.2% | 51.6% | 77% |
|
| F-Score | 2 | 4 | 7% |
|
Ainos, Inc. did not pass any screens on 9/4/2026.
